What Does Cannabis Rescheduling Mean for Hemp Beverages?
On April 23, 2026, the Department of Justice placed FDA-approved marijuana products and marijuana products subject to qualifying state medical licenses into […]
On April 23, 2026, the Department of Justice placed FDA-approved marijuana products and marijuana products subject to qualifying state medical licenses into […]
The cannabis industry has spent years waiting for this moment. As federal rescheduling moves forward, so do the opportunities to develop cannabinoid-based […]
Yesterday, the Pennsylvania Senate rejected SB 49, Sen. Dan Laughlin’s Cannabis Control Board bill, on a 27-23 floor vote. Then, within the […]
As federal policymakers move toward restricting hemp-derived cannabinoid products, a new state-level effort in Colorado is taking the opposite approach by moving […]
As the U.S. hemp industry braces for potential federal disruption later this year, a new bipartisan bill aims to give states a […]
A letter to California’s Assembly Committee on Business and Professions argues a proposed 10mg THC-per-package cap would eliminate 93% of beverage sales […]
California’s medical cannabis market began in 1996 when voters passed Proposition 215 (the Compassionate Use Act), making it the first state to […]
The Most Exciting US Market No cannabis market in the United States has experienced a more compelling growth trajectory over the past […]
Below are excerpts from the conversation at the White House press conference where President Trump signed an Executive Order to move marijuana […]
Minnesota has one of the most progressive markets in the US to normalize cannabis. Liquor stores can sell certain hemp-derived THC products, […]